Biblio

Assoum M, Philippe C, Isidor B, Perrin L, Makrythanasis P, Sondheimer N, Paris C, Douglas J, Lesca G, Antonarakis S et al..  2016.  Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy. AMERICAN JOURNAL OF HUMAN GENETICS. 99:1368-1376.

Courcet J-B, Elalaoui SChafai, Duplomb L, Tajir M, Riviere J-B, Thevenon J, Gigot N, Marle N, Aral B, Duffourd Y et al..  2015.  Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma. EUROPEAN JOURNAL OF HUMAN GENETICS. 23:957-962.

Tandon S.A, Kumar R., Parsana S..  2015.  Auxin treatment of wetland and non-wetland plant species to enhance their phytoremediation efficiency to treat municipal wastewater. JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH. 74:702-707.

Brembilla-Perrot B, Benichou M, Brembilla A, Bozec E, Dorlet S, Sellal JMarc, Olivier A, Manenti V, Villemin T, Beurrier D et al..  2015.  AV nodal reentrant tachycardia or AV reentrant tachycardia using a concealed bypass tract-related adverse events. INTERNATIONAL JOURNAL OF CARDIOLOGY. 199:84-89.

Baures R, Maquestiaux F, DeLucia PR, Defer A, Prigent E.  2018.  Availability of attention affects time-to-contact estimation. EXPERIMENTAL BRAIN RESEARCH. 236:1971-1984.

Webb A., Heldner M.R, D. de Sousa A, Sandset E.C, Randall G., Bejot Y., van der Worp B., Caso V., Fischer U., Sur ESO-SAFESecondary.  2019.  Availability of secondary prevention services after stroke in Europe: An ESO/SAFE survey of national scientific societies and stroke experts. EUROPEAN STROKE JOURNAL. 4:110-118.

Mathonier C, Meneveau N, Besutti M, Ecarnot F, Falvo N, Guillon B, Schiele F, Chopard R.  2021.  Available Bleeding Scoring Systems Poorly Predict Major Bleeding in the Acute Phase of Pulmonary Embolism. JOURNAL OF CLINICAL MEDICINE. 10:3615.

Mathonier C., Badoz M., Besutti M., Schiele F., Meneveau N., Guillon B., Chopard R..  2021.  Available bleeding scoring systems poorly predict major bleeding in the acute phase of pulmonary embolism. EUROPEAN HEART JOURNAL. 42:1925.

Patout M, Gagnadoux F, Rabec C, Trzepizur W, Georges M, Perrin C, Tamisier R, Llontop C, Goutorbe F, Gounane C et al..  2018.  AVAPS-AE vs. ST mode: A randomised controlled trial in patients with obesity hypoventilation syndrome. EUROPEAN RESPIRATORY JOURNAL. 52

Galle H.  2015.  Avatars of the Centaurs: from the myth to fantasy. STRENAE-RECHERCHES SUR LES LIVRES ET LES OBJETS CULTURELS DE L ENFANCE. 8

Coudert BP, Pierga J-Y, Mouret-Reynier M-A, Kerrou K, Ferrero J-M, Petit T, Kerbrat P, Dupre P-F, Bachelot TDenis, Gabelle P et al..  2014.  AVATAXHER: An open-label, randomized, multicenter study investigating the addition of bevacizumab (B) to neoadjuvant trastuzumab (T) plus docetaxel (D) in patients with early stage HER2-positive breast cancer (HER2+BC) stratified according to PET change a. JOURNAL OF CLINICAL ONCOLOGY. 32

Reck M, DeGreen HP, Rose AL, Pavlakis N, Derjcke SMaria, Radic J, Jeppesen N, Thomas M, Losonczy G, Kalinka-Warzocha E et al..  2016.  Avelumab (MSB0010718C; anti-PD-L1) vs platinum-based doublet as first-line treatment for metastatic or recurrent PD-L1-positive non-small-cell lung cancer: The phase 3 JAVELIN Lung 100 trial.. JOURNAL OF CLINICAL ONCOLOGY. 34

Taieb J, Andre T, Hajbi FEl, Barbier E, Toullec C, Kim S, Bouche O, Di Fiore F, Chauvenet M, Perrier H et al..  2021.  Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial. DIGESTIVE AND LIVER DISEASE. 53:318-323.

Tao Y, Auperin A, Sun XShan, Sire C, Martin L, Bera G., Coutte A, Miroir J, Lafond C, Colin-Batailhou N et al..  2018.  Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH). JOURNAL OF CLINICAL ONCOLOGY. 36

Tao Y, Auperin A, Sun X, Sire C, Martin L, Coutte A, Lafond C, Miroir J, Liem X, Rolland F et al..  2020.  Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH). EUROPEAN JOURNAL OF CANCER. 141:21-29.

Tao Y., Auperin A., Sun X., Sire C., Martin L., Coutte A., Lafond C., Miroir J., Liem X., Rolland F. et al..  2019.  Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH). ANNALS OF ONCOLOGY. 30:454.

Godichon-Baggioni A, Portier B.  2017.  An averaged projected Robbins-Monro algorithm for estimating the parameters of a truncated spherical distribution. ELECTRONIC JOURNAL OF STATISTICS. 11:1890-1927.

Blakemore RL, Sinanaj I, Galli S, Aybek S, Vuilleumier P.  2016.  Aversive stimuli exacerbate defensive motor behaviour in motor conversion disorder. NEUROPSYCHOLOGIA. 93:229-241.

De Heer F, Kluin J, Elkhoury G, Jondeau G, Enriquez-Sarano M, Schaefers H-J, Takkenberg JJM, Lansac E, Dinges C, Steindl J et al..  2019.  AVIATOR: An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 157:2202+.

De Heer F, Berrebi A, Borger M, Bouchot O, Cameron D, De Paulis R, Di Centa I, De Kerchove L, Khoury GEl, El-Hamamsy I et al..  2014.  AVIATOR Initiative: Aortic Valve Insufficiency and Ascending Aorta Aneurysm International Registry. CARDIOLOGY. 128:149-150.

De Heer F, Berrebi A, Borger M, Bouchot O, Cameron D, De Paulis R, Di Centa I, De Kerchove L, Khoury GEl, El-Hamamsy I et al..  2014.  AVIATOR Initiative: Aortic Valve Insufficiency and Ascending Aorta Aneurysm International Registry. CARDIOLOGY. 128:149-150.

Chalhoub H, Tunney M, J. Elborn S, Vergison A, Denis O, Plesiat P, Kahl BC, Van Bambeke F, Tulkens PM.  2015.  Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 70:1596-1598.

Baril J-L.  2016.  Avoiding patterns in irreducible permutations. DISCRETE MATHEMATICS AND THEORETICAL COMPUTER SCIENCE. 17:13-30.

Baril J-L.  2016.  Avoiding patterns in irreducible permutations. DISCRETE MATHEMATICS AND THEORETICAL COMPUTER SCIENCE. 17:13-30.

Vaillant L., Birgand G., Esposito-Farese M., Astagneau P., Pulcini C., Robert J., Zahar J.R, Sales-Wuillemin E., Tubach F., Lucet J.C et al..  2019.  Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL. 8:173.